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Objective: To study the prevalence of group B Streptococcus (GBS) colonization in  pregnant women and their 
newborns at Perugia General Hospital. 
Methods: The number of mother-child pairs examined was 2300. Vaginal swabs were collected from the mothers at 
delivery, and auricular and pharyngeal swabs and gastric aspirate from the newborns at birth. Maternal risk factors for 
GBS disease, including premature delivery, intrapartum fever, prolonged rupture of membranes and multiple births, 
were evaluated. 
Results: Maternal and neonatal colonization rates were 11.3% and 4.6%, respectively. GBS was isolated in  41.5% of 
the neonates born to colonized mothers and in 0.1% of those born to  non-colonized mothers. No significant difference 
was observed in  vertical transmission rates in the presence or absence of maternal risk factors. The external auditory 
canal was the most frequent (93.5%) and heavily colonized body site. Type Ib was the most common serotype among 
GBS isolates from mothers and babies. C surface protein was not detected in serotype V and Vlll isolates, but was 
frequent in all other serotypes. Early-onset disease was observed in 0.4/1000 live births. 
Conclusions: The prevalence of maternal and neonatal colonization at Perugia General Hospital was similar t o  that 
obtained in other studies performed in Italy. The external auditory canal was confirmed as the most reliable body site 
to be sampled for the detection of neonates exposed to maternal GBS colonization. 
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INTRODUCTION 
Neonatal group B Streptococcus (GBS) infection, a major 
cause of morbidity and mortality, occurs in two distinct 
syndromes of early- and late-onset disease [ 1,2]. Early- 
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onset infection is acquired from the mother by the 
ascending route in the uterus during labor or by direct 
contact at  delivery. It is characterized by fulminant 
pneumonia, meningitis and sepsis [3,4]. Late-onset 
disease occurs after the first week of life and may be 
acquired from the mother at the time of birth or later 
in life from other individuals [4]. The clinical features 
of late-onset disease are bacteremia, meningitis and 
septic arthritis. Approximately 10-30% of pregnant 
women are colonized with GBS [ 5 ] .  Many epidemio- 
logic and prevention studies have focused on coloniza- 
tion of pregnant women [6-81. 
GBS screening cultures, performed as close as 
possible to delivery, are recommended to detect carriers 
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and, therefore, potentially exposed neonates [9]. Fur- 
thermore, previous studies have identified maternal risk 
factors, such as prolonged rupture of membranes 
(PROM), intrapartum fever or endometritis, multiple 
births, Caesarean section and premature labor, as 
favoring neonatal GBS disease [4,7,10,11]. 
Data on GBS infection in Italy are scarce [12,13] 
but an increase in the incidence of such infections 
has been observed in many hospitals, especially in 
the last few years [14]. The aim of this study was to 
evaluate maternal and neonatal colonization of GBS 
in 2300 mother-child pairs admitted to the Neonatal 
and Obstetrics and Gynecology Divisions of Perugia 
General Hospital from March 1993 to September 
1995. 
MATERIALS AND METHODS 
Study population 
From March 1993 to September 1995 a prospective 
investigation was carried out on pregnant women 
and their newborns admitted to the Neonatal and 
Obstetrics and Gynecology Divisions of Perugia General 
Hospital, where about 1200 deliveries take place each 
year. The incidence of early-onset GBS disease per 
1000 live births was evaluated. GBS sepsis was defined 
as GBS-positive blood culture, which was performed 
always in the presence of clinical data suggestive of 
sepsis. Five risk factors for development of GBS disease 
were evaluated: (a) length of gestation (<37weeks); (b) 
intrapartuni fever (>38'C during labor); (c) prolonged 
membrane rupture (>12 h); (d) multiple births; (e) 
Caesarean section. 
Bacterial cultures and identification 
Low vaginal swabs from 2300 pregnant women were 
collected at the time of delivery, before any aseptic 
preparation. Culture specimens were obtained from the 
newborns at birth, before bathing. Auricular and 
pharyngeal swabs and gastric aspirate were collected. 
All specimens were maintained in Stuart transport 
medium (Becton Dickinson, Cockeysville, MD, USA) 
and delivered to the Microbiology Section of the 
Department of Experimental Medicine and Bio- 
chemical Sciences at  the University of Perugia, Perugia, 
Italy. The saniples were plated on selective media: GBS 
agar base Islam (Unipath Ltd, Basingstoke, Hampshire, 
UK) containing 5% inactivated horse serum, and 
Columbia colistin-nalidixic acid (CNA) agar (Unipath 
Ltd) with the addition of 5% defibrinated sheep blood. 
The GBS and CNA agar plates were incubated at  37 O C  
in anaerobic conditions and observed at 24 and 48 h. 
GBS growth on GBS agar was characterized by colonies 
with an orange carotenoid pigment. 0-Hemolytic 
colonies from CNA agar were u.sed to detect group B 
antigen by the latex agglutination test (Streptex, Murex 
Diagnostics, Dartford, Kent, UK;). 
The level of GBS colonization was determined on 
GBS agar plates by a semiquantit.ative four-zone streak- 
ing method. Growth of orange-colored colonies was 
recorded in quantities from 1' to 4+, with the score 
being given to the streaking quadrant having at least 
one orange colony. To standardize semiquantitation, a 
pure culture of a GBS reference strain was made and 
100 pL of serial 10-fold dilutions was inoculated on 
GBS agar and on two duplicate swabs. The swabs were 
then cultured on GBS agar usin,g the semiquantitative 
streaking method. A colony-forming units (CFU) /niL 
concentration of 102-10' corresponded to a GBS 
growth of 1+, 10' CFU/mL to 2+, lo6 CFU/mL to 
3 + ,  and > lo6  CFU/mL to 4.'. Light colonization 
was defined as a GBS growth of 1+/2+ and heavy 
colonization as a GBS growth of-3+/4+. 
Serotyping 
Thirty-seven GBS strains, isolat'ed from mothers and 
newborns in the last 6 months of the study, were 
serotyped according to standard procedures at  the 
WHO Reference Centre for Streptococci and Strepto- 
coccal Diseases at the Laboratory of Bacteriology and 
Medical Mycology of the Istituto Superiore di Saniti, 
Rome, Italy [13]. Briefly, GBS typing of capsular 
polysaccharides was carried out b y  Ouchterlony double 
agar immunodiffusion. Type-specific polysaccharides 
were obtained by extraction from the bacteria in 0.2 M 
HCl for 2 h at  50OC. The antigens were tested with 
specific antisera raised in New Zealand white rabbits 
according to the immunization xhedule described by 
Lancefield [15]. The antisera were prepared against the 
GBS polysaccharide types Ia, Ib, 11, 111, IV, V, VI, VII 
and VIII, and other typing markers of GBS, the surface- 
exposed proteins C and R. 
Therapy 
All newborns colonized by GES were treated with 
100 mg/kg/day of ampicillin, even in the absence of 
symptoms suggesting sepsis. Therapy started about 
24-30 h after birth and was maintained until negative 
cultures were obtained. The effect of antibiotic therapy 
was monitored daily by culturing auricular and 
pharyngeal swabs. Clinical and microbiological exami- 
nation of the newborns was repeated 20 days after 
birth. 
Statistical analysis 
Comparison of proportions and tests of significance 
were done using the chi-squared test. Statistical signi- 
ficance was defined as lW0.05. 
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RESULTS 
General data 
During the 2-year study, 2300 mothers and 2327 new- 
borns were examined. As shown in Table 1, pregnant 
women were classified on the basis of age, number of 
births and conditions of delivery. Most of the parturients 
were primiparae, 20-30 years of age, and had under- 
gone vaginal delivery. 
Frequency of mother-child GBS colonization 
Among the 2300 women studied, 260 carried GBS at 
delivery; the colonization rate was 11.3%. The rate of 
transmission of GBS to neonates was 41.5%. Among 
the 260 colonized mothers, 148 were heavily colonized 
and 112 showed light colonization. The number of 
colonized children from heavily colonized mothers was 
significantly higher (74/148) than that of those born to 
lightly colonized mothers (34/112), with a statistical 
significance of P<0.01. The level of GBS colonization 
was similar in mother and child (data not shown). All 
colonized mothers and their respective newborns were 
subdivided into two groups according to the presence 
or absence of risk factors at delivery. No significant 
differences were observed in the vertical transmission 
rates between the two groups (Table 2). 
Table 1 Study population 
Number % 
Total mothers examined 
Priniipara 
Pluripara 
Conditions of delivery 
Caesarean section 
Vaginal delivery 
Age of parturient 
<20 years 
20-30 years 
>30 years 
Total children examined 
2300 
1344 58.4 
956 41.6 
466 20.3 
1834 79.7 
24 0.6 
1396 60.8 
890 38.6 
2327a 
~ 
"During the 2-year study, 27 pairs of twins were born 
Neonatal colonization 
The sites and rates of colonization were evaluated in 
108 colonized neonates. As shown in Table 3, GBS was 
isolated from all sites sampled in 47.2% of the children, 
from two sites in 29.6% and from only one site in 23.2%. 
However, when the sampling sites were examined 
separately, the external auditory canal was the most 
frequently and heavily colonized body site (Table 4). 
The percentage of GBS isolation from auricular swabs 
was significantly higher than that observed with 
pharyngeal swabs or gastric aspirate (93.5% versus 72.2% 
and 58.3%, respectively). As described in Materials and 
Methods, the colonized children received antibiotics 
and microbiological follow-up until negative cultures 
were obtained. Thus, sequential controls after birth 
were performed. The first control, carried out on the 
second day after birth, showed that 42 children were 
still positive for GBS. The number of colonized 
newborns progressively decreased and no child was 
positive 5 days after birth. No growth of GBS was 
observed at follow-up, 20 days after birth (data not 
shown). 
Distribution of GBS serotypes 
Type Ib GBS was the most frequently isolated strain 
(27%) followed by type I1 and type 111 (21.6%), type Ia 
(16.2%), type V and type VIII (5.4%), and type IV 
(2.7%). Serotypes VI and VII were not detected. About 
80% of the infants who were colonized at birth had the 
same GBS serotype as their mothers, while the remain- 
ing 20% had types different from those of their mothers. 
Among GBS isolates from mothers and infants, the 
overall prevalence of C protein-positive strains was 
48.6%. This surface protein antigen was common 
among types Ia (66.7%), Ib (90%), I1 and 111 (25%), and 
IV (100%), but was not detected in the two type V 
strains or in the two type VIII strains. The R protein 
was found in type I1 and type I11 (75%), type V (SO%), 
and type VIII (100%). 
Table 2 Influence of maternal risk factors on neonatal colonization 
Neonatal sepsis 
During the study period, one case of early-onset disease 
was observed in a newborn female. Thus, the incidence 
Colonized mothers Colonized children Vertical transmission rate 
No. % No. % ("w 
With risk factors" 113 43.5 43 39.8 
Without risk factors 147 56.5 65 60.2 
38 
44.2b 
Total 260 100 108 100 
''Kisk factors are described in the text. 
bP=0.6 (colonized children from mothers with risk factors versus colonized children from mothers without risk factors). 
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of GBS sepsis in our study population was 0.4 per 1000 
live births (1 /2327). Vaginal colonization of the mother 
was light (GBS growth: 2+) but no risk factor was 
present at  delivery. The length of pregnancy was 40 
weeks. The child weighed 3.85 kg and the Apgar score 
was 9 at  1 and 5 min after birth. Seven hours after birth, 
she had respiratory distress and fever. A blood sample 
collected immediately yielded type 111 GBS. Type 111 
was also recovered from auricular and pharyngeal 
swabs. The newborn was treated with ampicillin (three 
doses per day, 40 nig/kg) plus gentamicin (two doses 
per day, 25 mg/kg) for 10 days. Her clinical conditions 
improved soon after the beginning of therapy, and 
complete recovery was achieved. 
DISCUSSION 
The prevalence of maternal colonization in the area 
of Perugia was 11.3% This value is similar to that 
obtained in the last multicenter study performed in 
Italy and in reports from other countries [12,16-181, 
where only vaginal colonization has been considered. 
A higher prevalence is observed when both vaginal and 
rectal swabs are cultured and different bacteriologic 
methods are employed [6,19-211. However, the reser- 
Table 3 Frequency of GRS colonization in different sites 
in children 
Samplesa No. O/o 
A+, P+, G+ 
A+, P+, G- 
A+, P-, G- 
A+, I)-, G+ 
A-, P , G+ 
A-, Pi, G+ 
A-, P+, G- 
Total 
51 47.2 
23 21.3 
20 18.5 
7 6.5 
3 2.8 
2 1.8 
2 1.8 
108 
“A, auricular swab; pharyngeal swab; G, gastric aspiratc 
Table 4 Levels of GBS colonization in different sites in 
108 positive children 
Samplesh 
A P G 
GBS colonizationA No. ’% No. 94 No. %I 
t / i i  27 25 27 
+ti/++++ 75 53 36 
Total 101 93.5‘ 78 72.2 63 58.3 
,‘GUS growth was quantified as described in the text. 
hA, auricular ywab; P, pharyngeal swab; G, gastric aspirate. 
‘P<O.OOl (A versus 1’ and G). 
voir for the transmission of GBS to the newborn is 
the birth canal. In particular, thle heaviness of vaginal 
carriage determines the rate of GBS transnlission from 
the mother to the baby [4,6]. In our study, the neonatal 
colonization rate was 4.6% and the vertical transmission 
rate of GBS from colonized mothers was 41.5%. 
This value is comparable to the 29-70% reported in 
industrialized countries [4]. Although the correlation 
between maternal risk factors a.nd the occurrence of 
neonatal GBS disease has been suggested [9,14,22], in 
our study no GBS sepsis occurred in neonates born to 
colonized mothers with risk factors. Furthermore, no 
significant difference was observed in the vertical 
transmission rates between the two groups (with or 
without risk factors). 
The body sites to be sampled in the newborn 
were chosen according to the following criteria: the 
external auditory canal has been reported as the most 
frequently colonized [4]; gastric: aspirate in the new- 
born closely resembles the amniotic fluid of the 
mother; a pharyngeal swab may >,how contamination of 
the airway from passage through the genital tract during 
delivery. Our results stress the reliability of sampling the 
external auditory canal. In fact, the auricular swab 
was able to identify 93.5% of the colonized children. 
O n  the other hand, gastric aspirate, which has been 
recognized by many authors as useful and highly 
sensitive for the detection of neonatal colonization 
[23-251, identified only 58% of all positive newborns. 
It  is important to point out that the first sampling was 
performed immediately after birth. Thus, at this time a 
positive result could reflect contarnination rather than 
true colonization [4]. However, in our study, neonato- 
logists chose to treat all exposed newborns in order to 
prevent late-onset disease; all newborns became negative 
within 5 days. 
Serotyping of GBS strains was performed only 
during the last period of the 5tudy. Thus, a greater 
collection of samples is required to confirm the pre- 
dominance of GBS serotype Ib in the area of Perugia. 
The only case of early-onset disease was caused by type 
111, a C protein-negative GBS strain, and occurred in a 
full-term neonate born to a lightly colonized mother 
without risk factors. This is not unusual, since it has 
been reported that light colonization causes up to 50%) 
of neonatal infections [13,26]. During the study period, 
the incidence of GBS sepsis was 0.4/1000 live births. 
This value might well have been different if a larger 
number of newborns had been exanlined. 
In conclusion, this study provides information 
on the pattern of GBS colonization in pregnant women 
and their newborns in central Italy. However, addi- 
tional studies are needed to define the status of GBS 
infection and to plan preventive measures in Italy. 
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